Enhancing Solubility and Bioavailability with Nanotechnology.

Detalles Bibliográficos
Publicado en:Pharmaceutical Technology Vol. 49; no. 3; pp. 16 - 19
Autor principal: Challener, Cynthia A.
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Apr2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184376791&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 184376791
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15432521
        4FK
      jtl: Pharmaceutical Technology
      issn: 15432521
      maglogo: N
    pubinfo:
      dt: Apr2025
      vid: 49
      iid: 3
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        184376791
        184376791
        184376791
        184376791
      ppf: 16
      ppct: 3
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Enhancing Solubility and Bioavailability with Nanotechnology.
      aug:
        au: Challener, Cynthia A.
      sug:
        subj:
          Drugs, Prescription Metabolism
          Solubility
          Biological Availability
          Nanotechnology
          Drugs, Prescription Pharmacokinetics
          United States Food and Drug Administration
          Chemistry, Pharmaceutical
          Technology, Pharmaceutical
          Drug Delivery Systems
          Drug Development
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N